Tau seeding activity in skin biopsy differentiates tauopathies from synucleinopathies
Most neurodegenerative diseases lack definitive diagnostic tests, and the identification of easily accessible and reliable biomarkers remains a critical unmet need. Since tau protein is highly expressed in skin of tauopathies patients, we aimed to exploit the ultrasensitive seeding activity assay (S...
Saved in:
| Published in | NPJ Parkinson's Disease Vol. 10; no. 1; pp. 116 - 12 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
Nature Publishing Group UK
15.06.2024
Nature Publishing Group Nature Portfolio |
| Subjects | |
| Online Access | Get full text |
| ISSN | 2373-8057 2373-8057 |
| DOI | 10.1038/s41531-024-00728-9 |
Cover
Loading…
| Abstract | Most neurodegenerative diseases lack definitive diagnostic tests, and the identification of easily accessible and reliable biomarkers remains a critical unmet need. Since tau protein is highly expressed in skin of tauopathies patients, we aimed to exploit the ultrasensitive seeding activity assay (SAA) to assess tau seeding activity in skin of patients with tauopathies. In this multicentric, case-control study, patients with tauopathies and synucleinopathies were consecutively recruited and sex-matched to healthy controls (HC). Subjects underwent a double 3 mm skin biopsy in cervical area and ankle. Skin tau-SAA, using TauK18 and TauK19 as reaction substrates for 4R and 3R isoforms, seeding score, clinical scales, biochemical and morphological characterization of SAA end-products were evaluated. We analyzed 58 subjects: 24 tauopathies (18 progressive supranuclear palsy, PSP, and 6 corticobasal degeneration, CBD), 20 synucleinopathies (14 Parkinson’s disease, PD, and 6 multiple system atrophy, MSA), and 14 HC. PSP and CBD showed higher tau seeding activity at both anatomical sites. A greater sensitivity of 4R-SAA than 3R-SAA was observed. 4R tau-SAA identified tauopathies with 71% sensitivity and 93% specificity. Accuracy was higher for PSP than CBD: PSP vs HC / PD (AUC 0.825), while CBD vs HC / PD (AUC 0.797), and PSP vs MSA (AU 0.778). SAA end-products showed differences in biochemical and morphological characterization according to the anatomical site. Skin tau-SAA identifies tauopathies with good accuracy and can be used to implement the in-vivo clinical diagnosis of patients with neurodegenerative diseases. Further characterization of peripheral tau seed in skin may elucidate the structure of tau deposits in brain. |
|---|---|
| AbstractList | Abstract Most neurodegenerative diseases lack definitive diagnostic tests, and the identification of easily accessible and reliable biomarkers remains a critical unmet need. Since tau protein is highly expressed in skin of tauopathies patients, we aimed to exploit the ultrasensitive seeding activity assay (SAA) to assess tau seeding activity in skin of patients with tauopathies. In this multicentric, case-control study, patients with tauopathies and synucleinopathies were consecutively recruited and sex-matched to healthy controls (HC). Subjects underwent a double 3 mm skin biopsy in cervical area and ankle. Skin tau-SAA, using TauK18 and TauK19 as reaction substrates for 4R and 3R isoforms, seeding score, clinical scales, biochemical and morphological characterization of SAA end-products were evaluated. We analyzed 58 subjects: 24 tauopathies (18 progressive supranuclear palsy, PSP, and 6 corticobasal degeneration, CBD), 20 synucleinopathies (14 Parkinson’s disease, PD, and 6 multiple system atrophy, MSA), and 14 HC. PSP and CBD showed higher tau seeding activity at both anatomical sites. A greater sensitivity of 4R-SAA than 3R-SAA was observed. 4R tau-SAA identified tauopathies with 71% sensitivity and 93% specificity. Accuracy was higher for PSP than CBD: PSP vs HC / PD (AUC 0.825), while CBD vs HC / PD (AUC 0.797), and PSP vs MSA (AU 0.778). SAA end-products showed differences in biochemical and morphological characterization according to the anatomical site. Skin tau-SAA identifies tauopathies with good accuracy and can be used to implement the in-vivo clinical diagnosis of patients with neurodegenerative diseases. Further characterization of peripheral tau seed in skin may elucidate the structure of tau deposits in brain. Most neurodegenerative diseases lack definitive diagnostic tests, and the identification of easily accessible and reliable biomarkers remains a critical unmet need. Since tau protein is highly expressed in skin of tauopathies patients, we aimed to exploit the ultrasensitive seeding activity assay (SAA) to assess tau seeding activity in skin of patients with tauopathies. In this multicentric, case-control study, patients with tauopathies and synucleinopathies were consecutively recruited and sex-matched to healthy controls (HC). Subjects underwent a double 3 mm skin biopsy in cervical area and ankle. Skin tau-SAA, using TauK18 and TauK19 as reaction substrates for 4R and 3R isoforms, seeding score, clinical scales, biochemical and morphological characterization of SAA end-products were evaluated. We analyzed 58 subjects: 24 tauopathies (18 progressive supranuclear palsy, PSP, and 6 corticobasal degeneration, CBD), 20 synucleinopathies (14 Parkinson's disease, PD, and 6 multiple system atrophy, MSA), and 14 HC. PSP and CBD showed higher tau seeding activity at both anatomical sites. A greater sensitivity of 4R-SAA than 3R-SAA was observed. 4R tau-SAA identified tauopathies with 71% sensitivity and 93% specificity. Accuracy was higher for PSP than CBD: PSP vs HC / PD (AUC 0.825), while CBD vs HC / PD (AUC 0.797), and PSP vs MSA (AU 0.778). SAA end-products showed differences in biochemical and morphological characterization according to the anatomical site. Skin tau-SAA identifies tauopathies with good accuracy and can be used to implement the in-vivo clinical diagnosis of patients with neurodegenerative diseases. Further characterization of peripheral tau seed in skin may elucidate the structure of tau deposits in brain. Most neurodegenerative diseases lack definitive diagnostic tests, and the identification of easily accessible and reliable biomarkers remains a critical unmet need. Since tau protein is highly expressed in skin of tauopathies patients, we aimed to exploit the ultrasensitive seeding activity assay (SAA) to assess tau seeding activity in skin of patients with tauopathies. In this multicentric, case-control study, patients with tauopathies and synucleinopathies were consecutively recruited and sex-matched to healthy controls (HC). Subjects underwent a double 3 mm skin biopsy in cervical area and ankle. Skin tau-SAA, using TauK18 and TauK19 as reaction substrates for 4R and 3R isoforms, seeding score, clinical scales, biochemical and morphological characterization of SAA end-products were evaluated. We analyzed 58 subjects: 24 tauopathies (18 progressive supranuclear palsy, PSP, and 6 corticobasal degeneration, CBD), 20 synucleinopathies (14 Parkinson's disease, PD, and 6 multiple system atrophy, MSA), and 14 HC. PSP and CBD showed higher tau seeding activity at both anatomical sites. A greater sensitivity of 4R-SAA than 3R-SAA was observed. 4R tau-SAA identified tauopathies with 71% sensitivity and 93% specificity. Accuracy was higher for PSP than CBD: PSP vs HC / PD (AUC 0.825), while CBD vs HC / PD (AUC 0.797), and PSP vs MSA (AU 0.778). SAA end-products showed differences in biochemical and morphological characterization according to the anatomical site. Skin tau-SAA identifies tauopathies with good accuracy and can be used to implement the in-vivo clinical diagnosis of patients with neurodegenerative diseases. Further characterization of peripheral tau seed in skin may elucidate the structure of tau deposits in brain.Most neurodegenerative diseases lack definitive diagnostic tests, and the identification of easily accessible and reliable biomarkers remains a critical unmet need. Since tau protein is highly expressed in skin of tauopathies patients, we aimed to exploit the ultrasensitive seeding activity assay (SAA) to assess tau seeding activity in skin of patients with tauopathies. In this multicentric, case-control study, patients with tauopathies and synucleinopathies were consecutively recruited and sex-matched to healthy controls (HC). Subjects underwent a double 3 mm skin biopsy in cervical area and ankle. Skin tau-SAA, using TauK18 and TauK19 as reaction substrates for 4R and 3R isoforms, seeding score, clinical scales, biochemical and morphological characterization of SAA end-products were evaluated. We analyzed 58 subjects: 24 tauopathies (18 progressive supranuclear palsy, PSP, and 6 corticobasal degeneration, CBD), 20 synucleinopathies (14 Parkinson's disease, PD, and 6 multiple system atrophy, MSA), and 14 HC. PSP and CBD showed higher tau seeding activity at both anatomical sites. A greater sensitivity of 4R-SAA than 3R-SAA was observed. 4R tau-SAA identified tauopathies with 71% sensitivity and 93% specificity. Accuracy was higher for PSP than CBD: PSP vs HC / PD (AUC 0.825), while CBD vs HC / PD (AUC 0.797), and PSP vs MSA (AU 0.778). SAA end-products showed differences in biochemical and morphological characterization according to the anatomical site. Skin tau-SAA identifies tauopathies with good accuracy and can be used to implement the in-vivo clinical diagnosis of patients with neurodegenerative diseases. Further characterization of peripheral tau seed in skin may elucidate the structure of tau deposits in brain. |
| ArticleNumber | 116 |
| Author | Ruiz-Barrio, Inigo Melli, Giorgia Legname, Giuseppe Celauro, Luigi Pagonabarraga, Javier Rossi, Stefania Dellarole, Ilaria Linda Raimondi, Andrea Kaelin-Lang, Alain Pinton, Sandra Vacchi, Elena Morandi, Sara Lombardo, Annalisa Kulisevsky, Jaime Bianco, Giovanni Begum Bacinoglu, Merve Gobbi, Claudio Staedler, Claudio Moda, Fabio Galati, Salvatore |
| Author_xml | – sequence: 1 givenname: Ilaria Linda surname: Dellarole fullname: Dellarole, Ilaria Linda organization: Division of Neurology 5 and Neuropathology, Fondazione IRCCS Istituto Neurologico Carlo Besta – sequence: 2 givenname: Elena orcidid: 0000-0002-8419-277X surname: Vacchi fullname: Vacchi, Elena organization: Neurodegenerative Diseases Group, Laboratories for Translational Research, Ente Ospedaliero Cantonale, Faculty of Biomedical Sciences, Università della Svizzera Italiana – sequence: 3 givenname: Inigo orcidid: 0000-0002-2015-5857 surname: Ruiz-Barrio fullname: Ruiz-Barrio, Inigo organization: Movement Disorders Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau – sequence: 4 givenname: Sandra surname: Pinton fullname: Pinton, Sandra organization: Neurodegenerative Diseases Group, Laboratories for Translational Research, Ente Ospedaliero Cantonale, Neurology Department, Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale – sequence: 5 givenname: Andrea surname: Raimondi fullname: Raimondi, Andrea organization: Institute for Research in Biomedicine, Università della Svizzera italiana – sequence: 6 givenname: Stefania surname: Rossi fullname: Rossi, Stefania organization: Neurology Department, Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale – sequence: 7 givenname: Sara surname: Morandi fullname: Morandi, Sara organization: Neurology Department, Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale – sequence: 8 givenname: Giovanni surname: Bianco fullname: Bianco, Giovanni organization: Neurology Department, Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale – sequence: 9 givenname: Merve surname: Begum Bacinoglu fullname: Begum Bacinoglu, Merve organization: Division of Neurology 5 and Neuropathology, Fondazione IRCCS Istituto Neurologico Carlo Besta – sequence: 10 givenname: Annalisa surname: Lombardo fullname: Lombardo, Annalisa organization: Division of Neurology 5 and Neuropathology, Fondazione IRCCS Istituto Neurologico Carlo Besta – sequence: 11 givenname: Luigi orcidid: 0000-0002-5731-3257 surname: Celauro fullname: Celauro, Luigi organization: Laboratory of Prion Biology, Department of Neuroscience, Scuola Internazionale Superiore Di Studi Avanzati (SISSA) – sequence: 12 givenname: Claudio surname: Staedler fullname: Staedler, Claudio organization: Neurology Department, Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale – sequence: 13 givenname: Salvatore surname: Galati fullname: Galati, Salvatore organization: Faculty of Biomedical Sciences, Università della Svizzera Italiana, Neurology Department, Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale – sequence: 14 givenname: Javier orcidid: 0000-0002-3248-704X surname: Pagonabarraga fullname: Pagonabarraga, Javier organization: Movement Disorders Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau – sequence: 15 givenname: Jaime orcidid: 0000-0003-4870-1431 surname: Kulisevsky fullname: Kulisevsky, Jaime organization: Movement Disorders Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau – sequence: 16 givenname: Giuseppe surname: Legname fullname: Legname, Giuseppe organization: Laboratory of Prion Biology, Department of Neuroscience, Scuola Internazionale Superiore Di Studi Avanzati (SISSA) – sequence: 17 givenname: Claudio surname: Gobbi fullname: Gobbi, Claudio organization: Faculty of Biomedical Sciences, Università della Svizzera Italiana, Neurology Department, Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale, Department of Neurology, University Hospital of Basel – sequence: 18 givenname: Alain surname: Kaelin-Lang fullname: Kaelin-Lang, Alain organization: Faculty of Biomedical Sciences, Università della Svizzera Italiana, Neurology Department, Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale, Department of Neurology, Inselspital, Bern University Hospital, University of Bern – sequence: 19 givenname: Fabio orcidid: 0000-0002-2820-9880 surname: Moda fullname: Moda, Fabio organization: Division of Neurology 5 and Neuropathology, Fondazione IRCCS Istituto Neurologico Carlo Besta – sequence: 20 givenname: Giorgia orcidid: 0000-0003-2069-4620 surname: Melli fullname: Melli, Giorgia email: giorgia.melli@eoc.ch organization: Neurodegenerative Diseases Group, Laboratories for Translational Research, Ente Ospedaliero Cantonale, Faculty of Biomedical Sciences, Università della Svizzera Italiana, Neurology Department, Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38879633$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9Uk1vGyEURFWqJk3zB3qoVuqll215fHOqqqgfkSL1kpwRZlkHdw0usJH874vtJE1yyAXQe_OGGZi36Cim6BF6D_gzYKq-FAacQo8J6zGWRPX6FTohVNJeYS6PHp2P0VkpK4wxMKE0x2_QMVVKakHpCbq-snNXvB9CXHbW1XAb6rYLsSt_2rIIaVO23RDG0Wcfa7DVl67aOW1svQntPOa07so2zm7yId6X36HXo52KP7vbT9H1j-9X57_6y98_L86_XfaOM6g94ZSDxaQZEkppgSXYAWBsTQeD1FoLNy4YUyAoUCk1JkKAloIzxpt8eoouDrxDsiuzyWFt89YkG8y-kPLS2FxD02YG4iT3kjpgllGG7SAXjBJBuOXKedW4vh64NvNi7QfX7GY7PSF92onhxizTrQEAhUHzxvDpjiGnv7Mv1axDcX6abPRpLoZioSRvtqBBPz6DrtKcY3urPYpp1mAN9eGxpAct99_XAOQAcDmVkv34AAFsdjExh5iYFhOzj4nZsapnQy5UW0Pa2QrTy6P0MFraPXHp83_ZL0z9Awi2zyQ |
| CitedBy_id | crossref_primary_10_1016_j_neubiorev_2024_105997 crossref_primary_10_1016_j_parkreldis_2025_107772 crossref_primary_10_1007_s00415_025_12994_5 crossref_primary_10_1016_S1474_4422_24_00487_3 |
| Cites_doi | 10.1007/978-981-32-9358-8_7 10.1007/s00401-014-1284-0 10.1212/WNL.0000000000000316 10.1093/brain/awad381 10.1016/j.neurobiolaging.2021.03.007 10.3390/brainsci10110815 10.1002/mds.21740 10.1038/s41531-021-00242-2 10.1111/j.1600-0447.2007.01038.x 10.1146/annurev-neuro-072116-031153 10.1038/s41582-020-0333-7 10.1007/s00401-018-1829-8 10.1212/WNL.0b013e31827f0fd1 10.1093/brain/awac161 10.1007/s00401-018-1876-1 10.1038/s41586-020-1984-7 10.1016/j.neuron.2023.05.017 10.1136/jnnp.55.3.181 10.1002/acn3.669 10.1093/brain/awm032 10.1002/mds.26987 10.1212/01.wnl.0000324625.00404.15 10.1186/s13024-021-00491-y 10.1007/s00401-018-1947-3 10.1111/jgs.15925 10.1186/s13024-022-00533-z 10.1007/s00415-021-10511-y 10.1002/mds.23429 10.1002/mds.28242 10.1111/nan.12792 10.1002/mds.29340 10.1007/s00401-019-02080-2 10.1002/ana.25446 10.1007/s00401-017-1692-z 10.1016/S0022-510X(99)00063-5 10.1002/mds.26293 10.1056/NEJMoa1404401 10.1038/s41531-021-00262-y 10.1212/WNL.0000000000206772 10.1039/D1CS00127B 10.1038/s41591-023-02358-9 10.1016/j.mayocp.2012.10.013 10.1523/JNEUROSCI.1230-17.2017 10.1002/mds.10473 10.1093/arclin/acs098 10.3390/ijms21145030 10.1186/s40035-019-0164-x |
| ContentType | Journal Article |
| Copyright | The Author(s) 2024 2024. The Author(s). The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2024 – notice: 2024. The Author(s). – notice: The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION NPM 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S PHGZM PHGZT PIMPY PKEHL PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1038/s41531-024-00728-9 |
| DatabaseName | SpringerOpen Free (Free internet resource, activated by CARLI) CrossRef PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Korea ProQuest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | PubMed Publicly Available Content Database CrossRef MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: 7X7 name: Health & Medical Collection url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2373-8057 |
| EndPage | 12 |
| ExternalDocumentID | oai_doaj_org_article_d2c75e73c14a4340ad7b432625a58ce8 PMC11180195 38879633 10_1038_s41531_024_00728_9 |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: PNRR-MAD-2022-12376035 – fundername: AFRI CTU-EOC 2023 Synapsis Foundation |
| GroupedDBID | 0R~ 3V. 53G 5VS 7X7 8FI 8FJ AAJSJ ABUWG ACGFS ACSMW ADBBV AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS BCNDV BENPR BPHCQ BVXVI C6C CCPQU EBLON EBS EMOBN FYUFA GROUPED_DOAJ HMCUK HYE M~E NAO NO~ OK1 PGMZT PIMPY PQQKQ PROAC RNT RPM SNYQT UKHRP AASML AAYXX CITATION PHGZM PHGZT NPM 7XB 8FK AARCD AZQEC DWQXO K9. PKEHL PQEST PQUKI PRINS 7X8 5PM PUEGO |
| ID | FETCH-LOGICAL-c541t-25351a0210368896071ad11f541c1d79996cfb448163137790266197654456333 |
| IEDL.DBID | C6C |
| ISSN | 2373-8057 |
| IngestDate | Wed Aug 27 01:31:43 EDT 2025 Thu Aug 21 18:33:46 EDT 2025 Fri Jul 11 04:43:39 EDT 2025 Wed Aug 13 05:15:08 EDT 2025 Mon Jul 21 06:01:49 EDT 2025 Thu Apr 24 23:09:25 EDT 2025 Tue Jul 01 01:42:12 EDT 2025 Fri Feb 21 02:40:29 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| License | 2024. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c541t-25351a0210368896071ad11f541c1d79996cfb448163137790266197654456333 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0002-2820-9880 0000-0003-2069-4620 0000-0002-2015-5857 0000-0002-8419-277X 0000-0002-5731-3257 0000-0003-4870-1431 0000-0002-3248-704X |
| OpenAccessLink | https://www.nature.com/articles/s41531-024-00728-9 |
| PMID | 38879633 |
| PQID | 3068494799 |
| PQPubID | 2041921 |
| PageCount | 12 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_d2c75e73c14a4340ad7b432625a58ce8 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11180195 proquest_miscellaneous_3068757991 proquest_journals_3068494799 pubmed_primary_38879633 crossref_primary_10_1038_s41531_024_00728_9 crossref_citationtrail_10_1038_s41531_024_00728_9 springer_journals_10_1038_s41531_024_00728_9 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2024-06-15 |
| PublicationDateYYYYMMDD | 2024-06-15 |
| PublicationDate_xml | – month: 06 year: 2024 text: 2024-06-15 day: 15 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: United States |
| PublicationTitle | NPJ Parkinson's Disease |
| PublicationTitleAbbrev | npj Parkinsons Dis |
| PublicationTitleAlternate | NPJ Parkinsons Dis |
| PublicationYear | 2024 |
| Publisher | Nature Publishing Group UK Nature Publishing Group Nature Portfolio |
| Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group – name: Nature Portfolio |
| References | NarasimhanSPathological Tau Strains from Human Brains Recapitulate the Diversity of Tauopathies in Nontransgenic Mouse BrainJ. Neurosci.20173711406114231:CAS:528:DC%2BC1cXhtlCjsbrO29054878570042310.1523/JNEUROSCI.1230-17.2017 HampelHBlood-based biomarkers for Alzheimer’s disease: Current state and future use in a transformed global healthcare landscapeNeuron2023111278127991:CAS:528:DC%2BB3sXht1WnsbnN3729542110.1016/j.neuron.2023.05.017 Steer, R. A., Brown, G. K., Pearson Education, I. & Psychological, C. BDI -II : Beck depression inventory. 2nd edn, (Pearson, 1996). BargarCDiscrimination of MSA-P and MSA-C by RT-QuIC analysis of olfactory mucosa: the first assessment of assay reproducibility between two specialized laboratoriesMol. Neurodegener.202116821:CAS:528:DC%2BB38Xpsl2ru7w%3D34895275866532710.1186/s13024-021-00491-y ArmstrongMJCriteria for the diagnosis of corticobasal degenerationNeurology20138049650323359374359005010.1212/WNL.0b013e31827f0fd1 Vacchi, E., Kaelin-Lang, A. & Melli, G. Tau and Alpha Synuclein Synergistic Effect in Neurodegenerative Diseases: When the Periphery Is the Core. Int. J. Mol. Sci. 21, https://doi.org/10.3390/ijms21145030 (2020). Bistaffa, E., Tagliavini, F., Matteini, P. & Moda, F. Contributions of Molecular and Optical Techniques to the Clinical Diagnosis of Alzheimer’s Disease. Brain Sci.10, https://doi.org/10.3390/brainsci10110815 (2020). HoglingerGUClinical diagnosis of progressive supranuclear palsy: The movement disorder society criteriaMov. Disord.20173285386428467028551652910.1002/mds.26987 NasreddineZSThe Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment (vol 53, pg 695, 2005)J. Am. Geriatr. Soc.20196719911991 SlettenDMSuarezGALowPAMandrekarJSingerWCOMPASS 31: a refined and abbreviated Composite Autonomic Symptom ScoreMayo Clin. Proc.2012871196120123218087354192310.1016/j.mayocp.2012.10.013 GersteneckerAExecutive dysfunction is the primary cognitive impairment in progressive supranuclear palsyArch. Clin. Neuropsychol.2013281041132312788210.1093/arclin/acs098 DopplerKDistinctive distribution of phospho-alpha-synuclein in dermal nerves in multiple system atrophyMov. Disord.201530168816921:CAS:528:DC%2BC2MXhslSrurrL2617530110.1002/mds.26293 GoedertMEisenbergDSCrowtherRAPropagation of Tau Aggregates and NeurodegenerationAnnu Rev. Neurosci.2017401892101:CAS:528:DC%2BC2sXht1yit7bF2877210110.1146/annurev-neuro-072116-031153 CandeliseNSeeding variability of different alpha synuclein strains in synucleinopathiesAnn. Neurol.2019856917031:CAS:528:DC%2BC1MXnvFOrtL8%3D3080595710.1002/ana.25446 KuzkinaADermal Real-Time Quaking-Induced Conversion Is a Sensitive Marker to Confirm Isolated Rapid Eye Movement Sleep Behavior Disorder as an Early alpha-SynucleinopathyMov. Disord.202338107710821:CAS:528:DC%2BB3sXjtVGgtL4%3D3675075510.1002/mds.29340 ZhangYWuKMYangLDongQYuJTTauopathies: new perspectives and challengesMol. Neurodegener.202217281:CAS:528:DC%2BB38XhtValsbbM35392986899170710.1186/s13024-022-00533-z Movement Disorder Society Task Force on Rating Scales for Parkinson’s Disease. The Unified Parkinson’s Disease Rating Scale (UPDRS): status and recommendations. Mov. Disord.18, 738–750 (2003). NolanoMSmall fiber pathology parallels disease progression in Parkinson disease: a longitudinal studyActa Neuropathol.20181365015032991603610.1007/s00401-018-1876-1 LauriaGEpidermal innervation: changes with aging, topographic location, and in sensory neuropathyJ. Neurol. Sci.19991641721781:STN:280:DyaK1MzivVCmtQ%3D%3D1040203010.1016/S0022-510X(99)00063-5 KrausASeeding selectivity and ultrasensitive detection of tau aggregate conformers of Alzheimer diseaseActa Neuropathol.20191375855983057067510.1007/s00401-018-1947-3 TomlinsonCLSystematic review of levodopa dose equivalency reporting in Parkinson’s diseaseMov. Disord.201025264926532106983310.1002/mds.23429 De LucaCMGEfficient RT-QuIC seeding activity for alpha-synuclein in olfactory mucosa samples of patients with Parkinson’s disease and multiple system atrophyTransl. Neurodegener.201982431406572668641110.1186/s40035-019-0164-x GilmanSSecond consensus statement on the diagnosis of multiple system atrophyNeurology2008716706761:STN:280:DC%2BD1crktlWmsA%3D%3D18725592267699310.1212/01.wnl.0000324625.00404.15 ManneSBlinded RT-QuIC Analysis of alpha-Synuclein Biomarker in Skin Tissue From Parkinson’s Disease PatientsMov. Disord.202035223022391:CAS:528:DC%2BB3MXlvFaqtg%3D%3D32960470774903510.1002/mds.28242 LunaEDifferential alpha-synuclein expression contributes to selective vulnerability of hippocampal neuron subpopulations to fibril-induced toxicityActa Neuropathol.20181358558751:CAS:528:DC%2BC1cXktVyqtrs%3D29502200595578810.1007/s00401-018-1829-8 ShahnawazMDiscriminating alpha-synuclein strains in Parkinson’s disease and multiple system atrophyNature20205782732771:CAS:528:DC%2BB3cXislCns70%3D32025029706687510.1038/s41586-020-1984-7 HoehnMMYahrMDParkinsonism: onset, progression, and mortality. 1967Neurology200157S11S261:STN:280:DC%2BD38%2Fks1ymug%3D%3D11775596 KovacsGGGhettiBGoedertMClassification of diseases with accumulation of Tau proteinNeuropathol. Appl Neurobiol.2022481:CAS:528:DC%2BB38Xht1aiu7jK35064600935214510.1111/nan.12792 GibbonsCCutaneous alpha-Synuclein Signatures in Patients With Multiple System Atrophy and Parkinson DiseaseNeurology2023100e1529e15391:CAS:528:DC%2BB3sXhtFyqt77I366579921010310710.1212/WNL.0000000000206772 VacchiEAlpha-synuclein oligomers and small nerve fiber pathology in skin are potential biomarkers of Parkinson’s diseaseNPJ Parkinsons Dis.202171191:CAS:528:DC%2BB38XivFOnsLc%3D34930911868848110.1038/s41531-021-00262-y PengCTrojanowskiJQLeeVMProtein transmission in neurodegenerative diseaseNat. Rev. Neurol.2020161992121:CAS:528:DC%2BB3cXlvFOlsb4%3D32203399924284110.1038/s41582-020-0333-7 PaltaPSex differences in in vivo tau neuropathology in a multiethnic sample of late middle-aged adultsNeurobiol. Aging20211031091161:CAS:528:DC%2BB3MXhs1yrt7zM33894641817820910.1016/j.neurobiolaging.2021.03.007 VacchiETau protein quantification in skin biopsies differentiates tauopathies from alpha-synucleinopathiesBrain2022145275527683548552710.1093/brain/awac161 ModaFPrions in the urine of patients with variant Creutzfeldt-Jakob diseaseN. Engl. J. Med.201437153053925099577416274010.1056/NEJMoa1404401 LimorenkoGLashuelHARevisiting the grammar of Tau aggregation and pathology formation: how new insights from brain pathology are shaping how we study and target TauopathiesChem. Soc. Rev.2022515135651:CAS:528:DC%2BB3MXislGis7%2FN3488993410.1039/D1CS00127B SaijoEUltrasensitive and selective detection of 3-repeat tau seeding activity in Pick disease brain and cerebrospinal fluidActa Neuropathol.20171337517651:CAS:528:DC%2BC2sXkt1Wmu7c%3D2829379310.1007/s00401-017-1692-z OkuzumiAPropagative alpha-synuclein seeds as serum biomarkers for synucleinopathiesNat. Med.202329144814551:CAS:528:DC%2BB3sXhtFWgt7jO372483021028755710.1038/s41591-023-02358-9 HughesAJDanielSEKilfordLLeesAJAccuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 casesJ. Neurol. Neurosurg. Psychiatry1992551811841:STN:280:DyaK383is1Omsg%3D%3D1564476101472010.1136/jnnp.55.3.181 KuzkinaADiagnostic value of skin RT-QuIC in Parkinson’s disease: a two-laboratory studyNPJ Parkinsons Dis.20217991:CAS:528:DC%2BB38XivFOhtLo%3D34782640859312810.1038/s41531-021-00242-2 SaijoE4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degenerationActa Neuropathol.202013963771:CAS:528:DC%2BC1MXhvFKrtrnK3161698210.1007/s00401-019-02080-2 BarghornSBiernatJMandelkowEPurification of recombinant tau protein and preparation of Alzheimer-paired helical filaments in vitroMethods Mol. Biol.200529935511:CAS:528:DC%2BD2MXkt12rtbc%3D15980594 GolbeLIOhman-StricklandPAA clinical rating scale for progressive supranuclear palsyBrain2007130155215651740576710.1093/brain/awm032 MelliGCervical skin denervation associates with alpha-synuclein aggregates in Parkinson diseaseAnn. Clin. Transl. Neurol.20185139414071:CAS:528:DC%2BC1cXitlGgtrzI30480033624338510.1002/acn3.669 DonadioVSkin nerve alpha-synuclein deposits: a biomarker for idiopathic Parkinson diseaseNeurology201482136213691:CAS:528:DC%2BC2cXmtFajsrs%3D2463445610.1212/WNL.0000000000000316 Tanaka, H. et al. Distinct involvement of the cranial and spinal nerves in progressive supranuclear palsy. Brain, https://doi.org/10.1093/brain/awad381 (2023). DopplerKCutaneous neuropathy in Parkinson’s disease: a window into brain pathologyActa Neuropathol.2014128991091:CAS:528:DC%2BC2cXntlyrtrs%3D24788821405996010.1007/s00401-014-1284-0 Horta-BarbaACognitive and behavioral profile of progressive supranuclear palsy and its phenotypesJ. Neurol.2021268340034083370455610.1007/s00415-021-10511-y CombsBMuellerRLMorfiniGBradySTKanaanNMTau and Axonal Transport Misregulation in TauopathiesAdv. Exp. Med. Biol.2019118481951:CAS:528:DC%2BB3cXis1anu7jJ32096030709958110.1007/978-981-32-9358-8_7 Stiasny-KolsterKThe REM sleep behavior disorder screening questionnaire-a new diagnostic instrumentMov. Disord.200722238623931789433710.1002/mds.21740 FolsteinMFFolsteinSEMcHughPRMini Mental State Examination (MMSE) - probably one of the most cited papers in health science - ReplyActa Psychiat Scand.200711615715710.1111/j.1600-0447.2007.01038.x S Barghorn (728_CR50) 2005; 299 K Doppler (728_CR28) 2014; 128 A Kuzkina (728_CR34) 2023; 38 C Bargar (728_CR17) 2021; 16 M Goedert (728_CR8) 2017; 40 S Manne (728_CR48) 2020; 35 N Candelise (728_CR16) 2019; 85 A Kuzkina (728_CR49) 2021; 7 Y Zhang (728_CR2) 2022; 17 A Horta-Barba (728_CR32) 2021; 268 GG Kovacs (728_CR3) 2022; 48 C Gibbons (728_CR30) 2023; 100 GU Hoglinger (728_CR35) 2017; 32 B Combs (728_CR4) 2019; 1184 728_CR1 H Hampel (728_CR23) 2023; 111 G Lauria (728_CR29) 1999; 164 S Gilman (728_CR38) 2008; 71 728_CR6 M Shahnawaz (728_CR10) 2020; 578 V Donadio (728_CR27) 2014; 82 728_CR40 728_CR43 MJ Armstrong (728_CR36) 2013; 80 E Vacchi (728_CR22) 2022; 145 K Doppler (728_CR21) 2015; 30 AJ Hughes (728_CR37) 1992; 55 DM Sletten (728_CR44) 2012; 87 F Moda (728_CR9) 2014; 371 CMG De Luca (728_CR12) 2019; 8 A Okuzumi (728_CR15) 2023; 29 MM Hoehn (728_CR39) 2001; 57 CL Tomlinson (728_CR47) 2010; 25 E Saijo (728_CR11) 2020; 139 G Melli (728_CR20) 2018; 5 A Gerstenecker (728_CR46) 2013; 28 LI Golbe (728_CR33) 2007; 130 K Stiasny-Kolster (728_CR45) 2007; 22 C Peng (728_CR24) 2020; 16 G Limorenko (728_CR5) 2022; 51 MF Folstein (728_CR41) 2007; 116 S Narasimhan (728_CR7) 2017; 37 E Vacchi (728_CR18) 2021; 7 E Saijo (728_CR13) 2017; 133 ZS Nasreddine (728_CR42) 2019; 67 A Kraus (728_CR14) 2019; 137 P Palta (728_CR31) 2021; 103 728_CR26 M Nolano (728_CR19) 2018; 136 E Luna (728_CR25) 2018; 135 |
| References_xml | – reference: DopplerKDistinctive distribution of phospho-alpha-synuclein in dermal nerves in multiple system atrophyMov. Disord.201530168816921:CAS:528:DC%2BC2MXhslSrurrL2617530110.1002/mds.26293 – reference: ModaFPrions in the urine of patients with variant Creutzfeldt-Jakob diseaseN. Engl. J. Med.201437153053925099577416274010.1056/NEJMoa1404401 – reference: NolanoMSmall fiber pathology parallels disease progression in Parkinson disease: a longitudinal studyActa Neuropathol.20181365015032991603610.1007/s00401-018-1876-1 – reference: HampelHBlood-based biomarkers for Alzheimer’s disease: Current state and future use in a transformed global healthcare landscapeNeuron2023111278127991:CAS:528:DC%2BB3sXht1WnsbnN3729542110.1016/j.neuron.2023.05.017 – reference: ArmstrongMJCriteria for the diagnosis of corticobasal degenerationNeurology20138049650323359374359005010.1212/WNL.0b013e31827f0fd1 – reference: Movement Disorder Society Task Force on Rating Scales for Parkinson’s Disease. The Unified Parkinson’s Disease Rating Scale (UPDRS): status and recommendations. Mov. Disord.18, 738–750 (2003). – reference: PaltaPSex differences in in vivo tau neuropathology in a multiethnic sample of late middle-aged adultsNeurobiol. Aging20211031091161:CAS:528:DC%2BB3MXhs1yrt7zM33894641817820910.1016/j.neurobiolaging.2021.03.007 – reference: De LucaCMGEfficient RT-QuIC seeding activity for alpha-synuclein in olfactory mucosa samples of patients with Parkinson’s disease and multiple system atrophyTransl. Neurodegener.201982431406572668641110.1186/s40035-019-0164-x – reference: SlettenDMSuarezGALowPAMandrekarJSingerWCOMPASS 31: a refined and abbreviated Composite Autonomic Symptom ScoreMayo Clin. Proc.2012871196120123218087354192310.1016/j.mayocp.2012.10.013 – reference: BargarCDiscrimination of MSA-P and MSA-C by RT-QuIC analysis of olfactory mucosa: the first assessment of assay reproducibility between two specialized laboratoriesMol. Neurodegener.202116821:CAS:528:DC%2BB38Xpsl2ru7w%3D34895275866532710.1186/s13024-021-00491-y – reference: KovacsGGGhettiBGoedertMClassification of diseases with accumulation of Tau proteinNeuropathol. Appl Neurobiol.2022481:CAS:528:DC%2BB38Xht1aiu7jK35064600935214510.1111/nan.12792 – reference: HoehnMMYahrMDParkinsonism: onset, progression, and mortality. 1967Neurology200157S11S261:STN:280:DC%2BD38%2Fks1ymug%3D%3D11775596 – reference: ZhangYWuKMYangLDongQYuJTTauopathies: new perspectives and challengesMol. Neurodegener.202217281:CAS:528:DC%2BB38XhtValsbbM35392986899170710.1186/s13024-022-00533-z – reference: DonadioVSkin nerve alpha-synuclein deposits: a biomarker for idiopathic Parkinson diseaseNeurology201482136213691:CAS:528:DC%2BC2cXmtFajsrs%3D2463445610.1212/WNL.0000000000000316 – reference: LimorenkoGLashuelHARevisiting the grammar of Tau aggregation and pathology formation: how new insights from brain pathology are shaping how we study and target TauopathiesChem. Soc. Rev.2022515135651:CAS:528:DC%2BB3MXislGis7%2FN3488993410.1039/D1CS00127B – reference: GibbonsCCutaneous alpha-Synuclein Signatures in Patients With Multiple System Atrophy and Parkinson DiseaseNeurology2023100e1529e15391:CAS:528:DC%2BB3sXhtFyqt77I366579921010310710.1212/WNL.0000000000206772 – reference: Tanaka, H. et al. Distinct involvement of the cranial and spinal nerves in progressive supranuclear palsy. Brain, https://doi.org/10.1093/brain/awad381 (2023). – reference: KuzkinaADermal Real-Time Quaking-Induced Conversion Is a Sensitive Marker to Confirm Isolated Rapid Eye Movement Sleep Behavior Disorder as an Early alpha-SynucleinopathyMov. Disord.202338107710821:CAS:528:DC%2BB3sXjtVGgtL4%3D3675075510.1002/mds.29340 – reference: GilmanSSecond consensus statement on the diagnosis of multiple system atrophyNeurology2008716706761:STN:280:DC%2BD1crktlWmsA%3D%3D18725592267699310.1212/01.wnl.0000324625.00404.15 – reference: KuzkinaADiagnostic value of skin RT-QuIC in Parkinson’s disease: a two-laboratory studyNPJ Parkinsons Dis.20217991:CAS:528:DC%2BB38XivFOhtLo%3D34782640859312810.1038/s41531-021-00242-2 – reference: VacchiEAlpha-synuclein oligomers and small nerve fiber pathology in skin are potential biomarkers of Parkinson’s diseaseNPJ Parkinsons Dis.202171191:CAS:528:DC%2BB38XivFOnsLc%3D34930911868848110.1038/s41531-021-00262-y – reference: BarghornSBiernatJMandelkowEPurification of recombinant tau protein and preparation of Alzheimer-paired helical filaments in vitroMethods Mol. Biol.200529935511:CAS:528:DC%2BD2MXkt12rtbc%3D15980594 – reference: NarasimhanSPathological Tau Strains from Human Brains Recapitulate the Diversity of Tauopathies in Nontransgenic Mouse BrainJ. Neurosci.20173711406114231:CAS:528:DC%2BC1cXhtlCjsbrO29054878570042310.1523/JNEUROSCI.1230-17.2017 – reference: PengCTrojanowskiJQLeeVMProtein transmission in neurodegenerative diseaseNat. Rev. Neurol.2020161992121:CAS:528:DC%2BB3cXlvFOlsb4%3D32203399924284110.1038/s41582-020-0333-7 – reference: FolsteinMFFolsteinSEMcHughPRMini Mental State Examination (MMSE) - probably one of the most cited papers in health science - ReplyActa Psychiat Scand.200711615715710.1111/j.1600-0447.2007.01038.x – reference: SaijoEUltrasensitive and selective detection of 3-repeat tau seeding activity in Pick disease brain and cerebrospinal fluidActa Neuropathol.20171337517651:CAS:528:DC%2BC2sXkt1Wmu7c%3D2829379310.1007/s00401-017-1692-z – reference: MelliGCervical skin denervation associates with alpha-synuclein aggregates in Parkinson diseaseAnn. Clin. Transl. Neurol.20185139414071:CAS:528:DC%2BC1cXitlGgtrzI30480033624338510.1002/acn3.669 – reference: CombsBMuellerRLMorfiniGBradySTKanaanNMTau and Axonal Transport Misregulation in TauopathiesAdv. Exp. Med. Biol.2019118481951:CAS:528:DC%2BB3cXis1anu7jJ32096030709958110.1007/978-981-32-9358-8_7 – reference: Horta-BarbaACognitive and behavioral profile of progressive supranuclear palsy and its phenotypesJ. Neurol.2021268340034083370455610.1007/s00415-021-10511-y – reference: Vacchi, E., Kaelin-Lang, A. & Melli, G. Tau and Alpha Synuclein Synergistic Effect in Neurodegenerative Diseases: When the Periphery Is the Core. Int. J. Mol. Sci. 21, https://doi.org/10.3390/ijms21145030 (2020). – reference: HughesAJDanielSEKilfordLLeesAJAccuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 casesJ. Neurol. Neurosurg. Psychiatry1992551811841:STN:280:DyaK383is1Omsg%3D%3D1564476101472010.1136/jnnp.55.3.181 – reference: Bistaffa, E., Tagliavini, F., Matteini, P. & Moda, F. Contributions of Molecular and Optical Techniques to the Clinical Diagnosis of Alzheimer’s Disease. Brain Sci.10, https://doi.org/10.3390/brainsci10110815 (2020). – reference: Steer, R. A., Brown, G. K., Pearson Education, I. & Psychological, C. BDI -II : Beck depression inventory. 2nd edn, (Pearson, 1996). – reference: SaijoE4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degenerationActa Neuropathol.202013963771:CAS:528:DC%2BC1MXhvFKrtrnK3161698210.1007/s00401-019-02080-2 – reference: KrausASeeding selectivity and ultrasensitive detection of tau aggregate conformers of Alzheimer diseaseActa Neuropathol.20191375855983057067510.1007/s00401-018-1947-3 – reference: DopplerKCutaneous neuropathy in Parkinson’s disease: a window into brain pathologyActa Neuropathol.2014128991091:CAS:528:DC%2BC2cXntlyrtrs%3D24788821405996010.1007/s00401-014-1284-0 – reference: HoglingerGUClinical diagnosis of progressive supranuclear palsy: The movement disorder society criteriaMov. Disord.20173285386428467028551652910.1002/mds.26987 – reference: ShahnawazMDiscriminating alpha-synuclein strains in Parkinson’s disease and multiple system atrophyNature20205782732771:CAS:528:DC%2BB3cXislCns70%3D32025029706687510.1038/s41586-020-1984-7 – reference: ManneSBlinded RT-QuIC Analysis of alpha-Synuclein Biomarker in Skin Tissue From Parkinson’s Disease PatientsMov. Disord.202035223022391:CAS:528:DC%2BB3MXlvFaqtg%3D%3D32960470774903510.1002/mds.28242 – reference: Stiasny-KolsterKThe REM sleep behavior disorder screening questionnaire-a new diagnostic instrumentMov. Disord.200722238623931789433710.1002/mds.21740 – reference: TomlinsonCLSystematic review of levodopa dose equivalency reporting in Parkinson’s diseaseMov. Disord.201025264926532106983310.1002/mds.23429 – reference: OkuzumiAPropagative alpha-synuclein seeds as serum biomarkers for synucleinopathiesNat. Med.202329144814551:CAS:528:DC%2BB3sXhtFWgt7jO372483021028755710.1038/s41591-023-02358-9 – reference: CandeliseNSeeding variability of different alpha synuclein strains in synucleinopathiesAnn. Neurol.2019856917031:CAS:528:DC%2BC1MXnvFOrtL8%3D3080595710.1002/ana.25446 – reference: GersteneckerAExecutive dysfunction is the primary cognitive impairment in progressive supranuclear palsyArch. Clin. Neuropsychol.2013281041132312788210.1093/arclin/acs098 – reference: GolbeLIOhman-StricklandPAA clinical rating scale for progressive supranuclear palsyBrain2007130155215651740576710.1093/brain/awm032 – reference: LunaEDifferential alpha-synuclein expression contributes to selective vulnerability of hippocampal neuron subpopulations to fibril-induced toxicityActa Neuropathol.20181358558751:CAS:528:DC%2BC1cXktVyqtrs%3D29502200595578810.1007/s00401-018-1829-8 – reference: LauriaGEpidermal innervation: changes with aging, topographic location, and in sensory neuropathyJ. Neurol. Sci.19991641721781:STN:280:DyaK1MzivVCmtQ%3D%3D1040203010.1016/S0022-510X(99)00063-5 – reference: VacchiETau protein quantification in skin biopsies differentiates tauopathies from alpha-synucleinopathiesBrain2022145275527683548552710.1093/brain/awac161 – reference: GoedertMEisenbergDSCrowtherRAPropagation of Tau Aggregates and NeurodegenerationAnnu Rev. Neurosci.2017401892101:CAS:528:DC%2BC2sXht1yit7bF2877210110.1146/annurev-neuro-072116-031153 – reference: NasreddineZSThe Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment (vol 53, pg 695, 2005)J. Am. Geriatr. Soc.20196719911991 – volume: 1184 start-page: 81 year: 2019 ident: 728_CR4 publication-title: Adv. Exp. Med. Biol. doi: 10.1007/978-981-32-9358-8_7 – volume: 128 start-page: 99 year: 2014 ident: 728_CR28 publication-title: Acta Neuropathol. doi: 10.1007/s00401-014-1284-0 – volume: 82 start-page: 1362 year: 2014 ident: 728_CR27 publication-title: Neurology doi: 10.1212/WNL.0000000000000316 – ident: 728_CR26 doi: 10.1093/brain/awad381 – volume: 103 start-page: 109 year: 2021 ident: 728_CR31 publication-title: Neurobiol. Aging doi: 10.1016/j.neurobiolaging.2021.03.007 – ident: 728_CR6 doi: 10.3390/brainsci10110815 – volume: 22 start-page: 2386 year: 2007 ident: 728_CR45 publication-title: Mov. Disord. doi: 10.1002/mds.21740 – volume: 7 start-page: 99 year: 2021 ident: 728_CR49 publication-title: NPJ Parkinsons Dis. doi: 10.1038/s41531-021-00242-2 – volume: 116 start-page: 157 year: 2007 ident: 728_CR41 publication-title: Acta Psychiat Scand. doi: 10.1111/j.1600-0447.2007.01038.x – volume: 40 start-page: 189 year: 2017 ident: 728_CR8 publication-title: Annu Rev. Neurosci. doi: 10.1146/annurev-neuro-072116-031153 – volume: 16 start-page: 199 year: 2020 ident: 728_CR24 publication-title: Nat. Rev. Neurol. doi: 10.1038/s41582-020-0333-7 – volume: 135 start-page: 855 year: 2018 ident: 728_CR25 publication-title: Acta Neuropathol. doi: 10.1007/s00401-018-1829-8 – volume: 80 start-page: 496 year: 2013 ident: 728_CR36 publication-title: Neurology doi: 10.1212/WNL.0b013e31827f0fd1 – volume: 145 start-page: 2755 year: 2022 ident: 728_CR22 publication-title: Brain doi: 10.1093/brain/awac161 – volume: 136 start-page: 501 year: 2018 ident: 728_CR19 publication-title: Acta Neuropathol. doi: 10.1007/s00401-018-1876-1 – volume: 578 start-page: 273 year: 2020 ident: 728_CR10 publication-title: Nature doi: 10.1038/s41586-020-1984-7 – volume: 111 start-page: 2781 year: 2023 ident: 728_CR23 publication-title: Neuron doi: 10.1016/j.neuron.2023.05.017 – volume: 55 start-page: 181 year: 1992 ident: 728_CR37 publication-title: J. Neurol. Neurosurg. Psychiatry doi: 10.1136/jnnp.55.3.181 – volume: 5 start-page: 1394 year: 2018 ident: 728_CR20 publication-title: Ann. Clin. Transl. Neurol. doi: 10.1002/acn3.669 – volume: 130 start-page: 1552 year: 2007 ident: 728_CR33 publication-title: Brain doi: 10.1093/brain/awm032 – volume: 32 start-page: 853 year: 2017 ident: 728_CR35 publication-title: Mov. Disord. doi: 10.1002/mds.26987 – volume: 299 start-page: 35 year: 2005 ident: 728_CR50 publication-title: Methods Mol. Biol. – volume: 57 start-page: S11 year: 2001 ident: 728_CR39 publication-title: Neurology – volume: 71 start-page: 670 year: 2008 ident: 728_CR38 publication-title: Neurology doi: 10.1212/01.wnl.0000324625.00404.15 – volume: 16 start-page: 82 year: 2021 ident: 728_CR17 publication-title: Mol. Neurodegener. doi: 10.1186/s13024-021-00491-y – volume: 137 start-page: 585 year: 2019 ident: 728_CR14 publication-title: Acta Neuropathol. doi: 10.1007/s00401-018-1947-3 – volume: 67 start-page: 1991 year: 2019 ident: 728_CR42 publication-title: J. Am. Geriatr. Soc. doi: 10.1111/jgs.15925 – ident: 728_CR43 – volume: 17 start-page: 28 year: 2022 ident: 728_CR2 publication-title: Mol. Neurodegener. doi: 10.1186/s13024-022-00533-z – volume: 268 start-page: 3400 year: 2021 ident: 728_CR32 publication-title: J. Neurol. doi: 10.1007/s00415-021-10511-y – volume: 25 start-page: 2649 year: 2010 ident: 728_CR47 publication-title: Mov. Disord. doi: 10.1002/mds.23429 – volume: 35 start-page: 2230 year: 2020 ident: 728_CR48 publication-title: Mov. Disord. doi: 10.1002/mds.28242 – volume: 48 year: 2022 ident: 728_CR3 publication-title: Neuropathol. Appl Neurobiol. doi: 10.1111/nan.12792 – volume: 38 start-page: 1077 year: 2023 ident: 728_CR34 publication-title: Mov. Disord. doi: 10.1002/mds.29340 – volume: 139 start-page: 63 year: 2020 ident: 728_CR11 publication-title: Acta Neuropathol. doi: 10.1007/s00401-019-02080-2 – volume: 85 start-page: 691 year: 2019 ident: 728_CR16 publication-title: Ann. Neurol. doi: 10.1002/ana.25446 – volume: 133 start-page: 751 year: 2017 ident: 728_CR13 publication-title: Acta Neuropathol. doi: 10.1007/s00401-017-1692-z – volume: 164 start-page: 172 year: 1999 ident: 728_CR29 publication-title: J. Neurol. Sci. doi: 10.1016/S0022-510X(99)00063-5 – volume: 30 start-page: 1688 year: 2015 ident: 728_CR21 publication-title: Mov. Disord. doi: 10.1002/mds.26293 – volume: 371 start-page: 530 year: 2014 ident: 728_CR9 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1404401 – volume: 7 start-page: 119 year: 2021 ident: 728_CR18 publication-title: NPJ Parkinsons Dis. doi: 10.1038/s41531-021-00262-y – volume: 100 start-page: e1529 year: 2023 ident: 728_CR30 publication-title: Neurology doi: 10.1212/WNL.0000000000206772 – volume: 51 start-page: 513 year: 2022 ident: 728_CR5 publication-title: Chem. Soc. Rev. doi: 10.1039/D1CS00127B – volume: 29 start-page: 1448 year: 2023 ident: 728_CR15 publication-title: Nat. Med. doi: 10.1038/s41591-023-02358-9 – volume: 87 start-page: 1196 year: 2012 ident: 728_CR44 publication-title: Mayo Clin. Proc. doi: 10.1016/j.mayocp.2012.10.013 – volume: 37 start-page: 11406 year: 2017 ident: 728_CR7 publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.1230-17.2017 – ident: 728_CR40 doi: 10.1002/mds.10473 – volume: 28 start-page: 104 year: 2013 ident: 728_CR46 publication-title: Arch. Clin. Neuropsychol. doi: 10.1093/arclin/acs098 – ident: 728_CR1 doi: 10.3390/ijms21145030 – volume: 8 start-page: 24 year: 2019 ident: 728_CR12 publication-title: Transl. Neurodegener. doi: 10.1186/s40035-019-0164-x |
| SSID | ssj0001468950 |
| Score | 2.3282247 |
| Snippet | Most neurodegenerative diseases lack definitive diagnostic tests, and the identification of easily accessible and reliable biomarkers remains a critical unmet... Abstract Most neurodegenerative diseases lack definitive diagnostic tests, and the identification of easily accessible and reliable biomarkers remains a... |
| SourceID | doaj pubmedcentral proquest pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 116 |
| SubjectTerms | 692/53/2421 692/617/375/365 Biomedical and Life Sciences Biomedicine Biopsy Morphology Neurology Neurosciences Skin |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NS-wwEB_Eg7zLw4-n1i8ivJsWmyZp06OKsgh6csFbaNMsLkpX7O7B_96ZpN23qz7f5V1KaaYQpjOZ3zSZ3wD8rmSVpCP6BWZtSgkKroO1oGM7GvGrciqTVO98e5cNhvLmQT0stPqiM2GBHjgo7qxOba5cLiyXpRQyKeu8kog5UlUqbZ0v88WYt5BM-b8rMtOFSroqmUTosxYjlcDMOZUxsWWjly9FIk_Y_xXK_HxY8sOOqQ9E1-vws0OQ7DzMfANWXLMJa7fdHvkWDO_LGWtDUGJUtkDdIdi4Ye0TXqrx5KV9Y31fFPRvxJpsWs4mvjcx3lPBCWvfGiI6Hjf9418wvL66vxzEXfOE2CrJp3GqhOIlZXQi07ogGrmy5nyEg5bXOeU5dlRhcoaALLAOUqhGcELsPJkQYhtWm0njdoFJWVhEKjiulXSS65EVKJS7PE8yy3UEvFeksR2zODW4eDZ-h1toE5RvUPnGK98UEZzM33kJvBrfSl_Q95lLEie2f4CWYjpLMf-ylAgO-q9rOkdtDWZMWhYS9RHB8XwYXYz2TcrGTWZBJlcowiPYCcYwn4nARRrXMBGBXjKTpakujzTjR0_jzYl9jxcqgtPeov7M6--62PsfutiHH6l3hSzm6gBWp68zd4joalodeUd6B89qGu4 priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swED-6DsZexrp2m7e2aLC31tSyJEt-GltpKYX2qYG8CVtWtrBiZ3Xy0P9-d7KckH30xQTrDMrpPnXS7wA-17LO8hltgTmXU4KCdrARdGzHYPyqvCok3Xe-uS2uJvJ6qqZxw62PxypHmxgMddM52iM_w9DWyFLqsvyy-JVS1yiqrsYWGs_gOUGXUfKlp3qzxyILU6os3pXJhDnr0V8JzJ9zmRJmNur6lj8KsP3_ijX_PjL5R900uKPL1_AqxpHs67Dwe7Dj2zfw4iZWyvdhcletWD-4JkaXF6hHBJu3rP-Jj3reLfpHNnZHQS3HiJMtq1UXOhTjb7p2wvrHluCO5-34-gAmlxd351dpbKGQOiX5Ms2VULyivE4UxpQEJlc1nM9w0PFGU7bjZjWmaBiWDdiD5LAxRCGMnkII8RZ2267174FJWTqMV3DcKOklNzMnkEh7rbPCcZMAHxlpXcQXpzYX9zbUuYWxA_MtMt8G5tsygZP1N4sBXeNJ6m-0PmtKQsYOL7qH7zYqmm1yp5XXwnFZSSGzqtG1xBg1V5UyzuM0D8fVtVFde7sRrgQ-rYdR0ah6UrW-Ww00WiEJT-DdIAzrmQg01WjJRAJmS0y2pro90s5_BDBvThh8KLsJnI4StZnX_3nx4em_8RFe5kHIi5SrQ9hdPqz8EUZPy_o4qMhvJuoS6g priority: 102 providerName: ProQuest |
| Title | Tau seeding activity in skin biopsy differentiates tauopathies from synucleinopathies |
| URI | https://link.springer.com/article/10.1038/s41531-024-00728-9 https://www.ncbi.nlm.nih.gov/pubmed/38879633 https://www.proquest.com/docview/3068494799 https://www.proquest.com/docview/3068757991 https://pubmed.ncbi.nlm.nih.gov/PMC11180195 https://doaj.org/article/d2c75e73c14a4340ad7b432625a58ce8 |
| Volume | 10 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9wwDBf9gLGX0nUfzdodHuxtC4tjO3Yer0dLOWgZWw_uzSSObzs2ktLcPfS_n-QkV27rBn1JQqyAUCRLsqWfAT6UskzSBS2BOZdSgoLzYCWobMdg_Kq8yiT1O19dZ5czOZ2r-Q6kQy9MKNoPkJZhmh6qwz636GgEJr6pjAnsGo10F_YJup3K-CbZ5GFdRWYmV0nfH5MI88inWz4oQPU_Fl_-XSb5x15pcEEXh3DQx45s3HH7AnZ8fQTPrvrd8ZcwuynWrO3cEaOGBToXgi1r1v7ES7lsbtt7NpyIgpaNUSZbFesmnEqMz9Rqwtr7miCOl_Xw-hXMLs5vJpdxf2xC7JTkqzhVQvGCcjmRGZMTgFxRcb7AQccrTRmOW5SYlmEo1uENkpPGsIRweTIhxGvYq5vaHwOTMncYo-C4UdJLbhZOIJH2WieZ4yYCPgjSuh5TnI62-GXD3rYwthO-ReHbIHybR_Bx881th6jxX-oz-j8bSkLDDi-au--21w5bpU4rr4XjspBCJkWlS4lxaaoKZZxHNk-Hv2t7E20t5kpG5hLlEcH7zTAaF-2YFLVv1h2NVkjCI3jTKcOGE4HTM85eIgKzpSZbrG6P1MsfAcCbE-4ez1UEnwaNeuDr37J4-zTyE3ieBqXPYq5OYW91t_bvMIJalSPY1XM9gv3xePptivez8-svX0fBkEZhVeI3--MVhg |
| linkProvider | Springer Nature |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED9NnQS8IL4XNsBI8ATR4thOnAc0MdjUsbVCqJX2ZhLHhQqUdEsr1H-Kv3F3-WhVPva2l6iKL5J7Pt_9zue7A3iVySwIJ3QEZm1IDgrqwVzQtR2N-FU5FUnKdx4Mo_5YfjpX51vwu8uFoWuVnU6sFXVeWjoj30doq2Ui4yQ5mF341DWKoqtdC41GLE7d8he6bNW7k4-4vq_D8Pho9KHvt10FfKskn_uhEoqn5OqISOuE6qulOecTHLQ8j8kBsJMMvRZEKk05PrJhaLWpbE0k6AAUVf62FAgVerB9eDT8_GV9qiMjnaigzc4JhN6v0EIK9NhD6VOVbtQuGxawbhTwL3T79yXNPyK1tQE8vgd3W-TK3jeidh-2XPEAbg3a2PxDGI_SBasaY8goXYK6UrBpwaof-Mim5axasq4fC-oVxLhsni7Kuicy_qZEF1YtCyqwPC26149gfCPsfQy9oizcDjApE4sICce1kk5yPbECiWIXx0FkufaAd4w0tq1oTo01fpo6si60aZhvkPmmZr5JPHiz-mbW1PO4lvqQ1mdFSbW46xfl5TfTbm2ThzZWLhaWy1QKGaR5nElExaFKlbYOp7nXra5pFURl1uLswcvVMG5titekhSsXDU2skIR78KQRhtVMBBoH1J3CA70hJhtT3Rwppt_r8uGcqv7xRHnwtpOo9bz-z4un1_-NF3C7PxqcmbOT4eku3AlrgY98rvagN79cuGeI3ebZ83bDMPh603v0CqH4S10 |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED9NQ5p4QXwTGBAkeIKocWzHzgNCwKg2xiYeVqlvJnGcUYGSsrRC_df467hzklblY297qar4Wjnn-7R9vwN4XogiTiraArM2oQQF7WDJ6dqOxvhVOpkKqnc-OU0PJ-LjVE534NdQC0PXKgeb6A112VjaIx9haKtFJlSWjar-WsTng_Gb-Y-IOkjRSevQTqMTkWO3-onpW_v66ADX-kWSjD-cvT-M-g4DkZWCLaJEcslySnt4qnVGWGt5yViFg5aVipIBWxWYwWDU0kHzkT9DD04QNimnzVA0_9cU_gt1T1BTtdnfEanOZNzX6cRcj1r0lRxz90REhNeNdmbLF_qWAf-Kc_--rvnHma13heObcKOPYcO3ndDdgh1X34a9k_6U_g5MzvJl2HZuMaTCCepPEc7qsP2GH8WsmbercOjMghYGo91wkS8b3x0Zv1PJS9iuaoJantXD47swuRLm3oPduqndAwiFyCzGSjiupXCC6cpyJFJOqTi1TAfABkYa22ObU4uN78afsXNtOuYbZL7xzDdZAC_Xv5l3yB6XUr-j9VlTEiq3f9BcnJteyU2ZWCWd4paJXHAR56UqBMbHicyltg6nuT-srulNRWs2gh3As_UwKjmd3OS1a5YdjZJIwgK43wnDeiYc3QRaUR6A3hKTraluj9Szrx5InBH-H8tkAK8GidrM6_-8eHj5azyFPdRM8-no9PgRXE-8vKcRk_uwu7hYuscYxC2KJ15bQvhy1er5G9ycTi0 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Tau+seeding+activity+in+skin+biopsy+differentiates+tauopathies+from+synucleinopathies&rft.jtitle=NPJ+Parkinson%27s+Disease&rft.au=Dellarole%2C+Ilaria+Linda&rft.au=Vacchi%2C+Elena&rft.au=Ruiz-Barrio%2C+Inigo&rft.au=Pinton%2C+Sandra&rft.date=2024-06-15&rft.issn=2373-8057&rft.eissn=2373-8057&rft.volume=10&rft.issue=1&rft.spage=116&rft_id=info:doi/10.1038%2Fs41531-024-00728-9&rft_id=info%3Apmid%2F38879633&rft.externalDocID=38879633 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2373-8057&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2373-8057&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2373-8057&client=summon |